These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9838466)

  • 1. HBV prophylaxis: cost/benefit analysis following liver transplantation for HBV-positive liver cirrhosis.
    Golling M; Arnold JC; Rudek B; Mehrabi A; Kraus T; Herfarth C; Klar E
    Transplant Proc; 1998 Nov; 30(7):3316-7. PubMed ID: 9838466
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver transplantation for hepatitis B: the con aspect.
    Wiesner RH; Krom RA
    Liver Transpl Surg; 1995 Jul; 1(4):265-70. PubMed ID: 9346580
    [No Abstract]   [Full Text] [Related]  

  • 3. Absence of initial viral replication and long-term high dose immunoglobulin administration improve results of hepatitis B virus recurrence prophylaxis after liver transplantation.
    Gugenheim J; Baldini E; Ouzan D; Mouiel J
    Transplant Proc; 1997; 29(1-2):517-8. PubMed ID: 9123112
    [No Abstract]   [Full Text] [Related]  

  • 4. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
    Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allograft biopsies in situ hybridization HBVDNA detection of serum HBs Ag-repositive patients treated with anti-HBV immunoprophylaxis after liver transplantation for HBV cirrhosis.
    Reynès M; Tricottet V; Samuel D; Sebagh M; Bismuth A; Arulnaden J; Brechot C; Bismuth H
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1347-8. PubMed ID: 8442139
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of antiviral therapy on the natural history of hepatitis B virus recurrence after liver transplantation: retrospective study of 14 cases.
    Vizuete SG; Encinas JL; Prados E; Haro J; Cuervas-Mons V
    Transplant Proc; 1999 Sep; 31(6):2461-3. PubMed ID: 10500671
    [No Abstract]   [Full Text] [Related]  

  • 7. Developing strategies for prevention and treatment of recurrent HBV in liver transplantation.
    Nery JR; Weppler D; Lavandera R; Nery Avila C; Magill A; Rodriguez M; Reddy KR; Schiff E; Tzakis AG
    Transplant Proc; 1999; 31(1-2):485-6. PubMed ID: 10083202
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoprophylaxis for hepatitis B virus reinfection after liver transplantation.
    Jeng LB; Lee WC; Yeh DS; Wang CC; Wang KL; Chen SC; Chen MF; Chien RN; Chiu CT; Lin DY
    Transplant Proc; 1994 Aug; 26(4):2243-4. PubMed ID: 8066736
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B immune globulin dose requirements following orthotopic liver transplantation for chronic hepatitis B cirrhosis.
    McGory R; Ishitani M; Oliveira W; Stevenson W; McCullough C; Pruett T
    Transplant Proc; 1996 Jun; 28(3):1687-8. PubMed ID: 8658840
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of recurrent hepatitis B after OLT in patients treated with HBIG prophylaxis using graft-biopsy staining, anti-HBs titers and hepatitis B serology.
    Nymann T; Adamec T; Shokouh-Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1997; 29(1-2):507-8. PubMed ID: 9123106
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B-associated liver cirrhosis as an indication for liver transplantation.
    Jansen PL; Haagsma EB; Klompmaker IJ; Cuypers HT; Karrenbeld A; Gouw AS; Slooff MJ
    Scand J Gastroenterol Suppl; 1995; 212():19-22. PubMed ID: 8578227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for hepatitis B.
    Schiff ER
    Liver Transpl Surg; 1995 Jul; 1(4):259-60. PubMed ID: 9346578
    [No Abstract]   [Full Text] [Related]  

  • 13. Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation.
    Singer GA; Zielsdorf S; Fleetwood VA; Alvey N; Cohen E; Eswaran S; Shah N; Chan EY; Hertl M; Fayek SA
    Transplant Proc; 2015 Mar; 47(2):478-84. PubMed ID: 25769595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful retransplantation for recurrent posttransplant hepatitis B virus infection in the primary allograft.
    Ishitani M; McGory R; Dickson R; Caldwell S; Bickston S; McCullough C; Pruett T
    Transplant Proc; 1996 Jun; 28(3):1714-6. PubMed ID: 8658852
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation.
    Rosenau J; Tillmann HL; Bahr MJ; Trautwein C; Boeker KH; Nashan B; Klempnauer J; Manns MP
    Transplant Proc; 2001; 33(7-8):3637-8. PubMed ID: 11750544
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
    Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
    J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of low-dose intramuscular anti-VHB immune globulin in the prophylaxis of viral B hepatitis reinfection after liver transplantation: preliminary report.
    Alonso I; Herreros de Tejada A; Moreno JM; Rubio E; Lucena JL; De la Revilla J; Sánchez Turrión V; Gomez A; Lopez J; Cuervas-Mons V
    Transplant Proc; 2003 Aug; 35(5):1850-1. PubMed ID: 12962821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for hepatitis B virus infection.
    Samuel D; Alexander G
    Liver Transpl Surg; 1995 Jul; 1(4):270-4. PubMed ID: 9346581
    [No Abstract]   [Full Text] [Related]  

  • 19. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft.
    Ishitani M; McGory R; Dickson R; Caldwell S; Bickston S; McCullough C; Pruett T; Terrault N; Roberts J; Ascher N; Wright T; Lake J
    Transplantation; 1997 Aug; 64(3):410-4. PubMed ID: 9275104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
    Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
    Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.